Medical Doctor Program year 2022 Source: CMS Open Payments, 2026 publication

Chad Evans

Neurology Minneapolis, MN Medical Doctor

NPI 1417976077 CMS profile 1030181

3601 Minnesota Dr Ste 200, Ste 100, Minneapolis, MN 55435

Open in the dashboard

General payments

$235

2 records reported · program year 2022

Research payments

$0

Paid to them · None reported · program year 2022

Ownership & investment interest

$0

None reported

Through program year 2022, Chad Evans of Minneapolis, MN is reported in the CMS Open Payments database as having received $235 across 2 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 25th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2022 General $235 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chad Evans
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Chad Evans were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Chad Evans Neurology median Middle half National median
2019 $0 $474 $118–$2,177 $163
2020 $0 $367 $82–$2,309 $114
2021 $0 $438 $104–$2,547 $132
2022 $235 $442 $103–$2,388 $149
2023 $0 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program year 2022
  1. Medtronic, Inc. $235 2 payments

Every payment, record by record

What the payments were for General payments · program year 2022
  1. Travel and Lodging $235 2 payments
Products named General payments · program year 2022
  1. MAZOR X SYSTEM $235 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 41 drugs

Part D claims

1,740

Median for Neurology: 833

Drug cost

$146,483

Median for Neurology: $202,670

Branded share of claims

26.4%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ubrelvy Ubrogepant Brand 38 $47,770
Aimovig Autoinjector Erenumab-Aooe Brand 50 $36,408
Sumatriptan Succinate Generic 59 $10,593
Levetiracetam Generic 189 $5,548
Dilantin Phenytoin Sodium Extended Brand 27 $5,047
Aricept Donepezil Hcl Brand 11 $4,824
Baclofen Generic 39 $4,406
Gabapentin Generic 174 $4,163
Carbidopa-Levodopa Carbidopa/Levodopa Brand 145 $3,602
Pyridostigmine Bromide Generic 20 $2,219

The 10 drugs with the highest cost, of 41 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$324,271

Of which drugs: $240,243

Medicare patients

525

Average age 69

Services billed

20,667

311 women, 214 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 58%
Arthritis 47%
Depression 35%
Ischemic heart disease 24%
Diabetes 22%
Chronic kidney disease 21%
Osteoporosis 14%
Alzheimer's or dementia 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, eptinezumab-jjmr, 1 mg J3032 Office 13 4,400 $62,681
Injection, abobotulinumtoxina, 5 units J0586 Office 14 2,435 $16,454
Injection, onabotulinumtoxina, 1 unit J0585 Office 12 2,800 $12,482
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 37 630 $54

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record